CEP55作为一个有前途的生物标志物和治疗点在胆囊癌

Maotuan Huang1,2,3,4, Fuxiu Zhong1,2,5, Mingyuan Chen1,2,3,4

  • 1Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.

PubMed
概括

向CEP55对胆囊癌 (GBC) 治疗有希望. 抑制CEP55抑制了GBC细胞的增殖并诱导了细胞亡,为这种侵略性癌症提供了潜在的新疗法策略.